BioSpectrum Asia, one of Asia’s leading life sciences and biotech publications, featured 1Cell.ai in an industry analysis piece on how AI is transforming cancer diagnostics across the region. We were highlighted for our application of AI to single-cell analysis for detecting circulating tumour cells from blood samples, recognising our platform as one of the key innovations driving early diagnosis and disease monitoring in the precision oncology space.